rs56393253

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_033087.4(ALG2):​c.1132C>T​(p.Arg378Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000573 in 1,614,126 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R378H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00058 ( 2 hom. )

Consequence

ALG2
NM_033087.4 missense

Scores

2
8
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 4.40

Publications

4 publications found
Variant links:
Genes affected
ALG2 (HGNC:23159): (ALG2 alpha-1,3/1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 1 family. The encoded protein acts as an alpha 1,3 mannosyltransferase, mannosylating Man(2)GlcNAc(2)-dolichol diphosphate and Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-dolichol diphosphate. Defects in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ii). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
ALG2 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 14
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • ALG2-congenital disorder of glycosylation
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P, Orphanet
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07675636).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000512 (78/152276) while in subpopulation AFR AF = 0.000914 (38/41560). AF 95% confidence interval is 0.000684. There are 0 homozygotes in GnomAd4. There are 35 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 Unknown,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033087.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG2
NM_033087.4
MANE Select
c.1132C>Tp.Arg378Cys
missense
Exon 2 of 2NP_149078.1Q9H553-1
ALG2
NR_024532.2
n.1339C>T
non_coding_transcript_exon
Exon 3 of 3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG2
ENST00000476832.2
TSL:1 MANE Select
c.1132C>Tp.Arg378Cys
missense
Exon 2 of 2ENSP00000417764.1Q9H553-1
ALG2
ENST00000319033.7
TSL:1
c.853C>Tp.Arg285Cys
missense
Exon 2 of 2ENSP00000326609.6Q9H553-2
ALG2
ENST00000906837.1
c.985C>Tp.Arg329Cys
missense
Exon 2 of 2ENSP00000576896.1

Frequencies

GnomAD3 genomes
AF:
0.000513
AC:
78
AN:
152158
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000346
AC:
87
AN:
251412
AF XY:
0.000309
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000413
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000579
AC:
847
AN:
1461850
Hom.:
2
Cov.:
31
AF XY:
0.000518
AC XY:
377
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.00140
AC:
47
AN:
33462
American (AMR)
AF:
0.000447
AC:
20
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000656
AC:
730
AN:
1112000
Other (OTH)
AF:
0.000646
AC:
39
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000512
AC:
78
AN:
152276
Hom.:
0
Cov.:
33
AF XY:
0.000470
AC XY:
35
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41560
American (AMR)
AF:
0.000457
AC:
7
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000470
AC:
32
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000435
Hom.:
0
Bravo
AF:
0.000582
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000305
AC:
37
EpiCase
AF:
0.000600
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 (2)
-
1
-
ALG2-congenital disorder of glycosylation (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.25
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.60
D
Eigen
Pathogenic
0.72
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.077
T
MetaSVM
Uncertain
0.10
D
MutationAssessor
Uncertain
2.4
M
PhyloP100
4.4
PrimateAI
Benign
0.21
T
PROVEAN
Uncertain
-4.2
D
REVEL
Uncertain
0.37
Sift
Uncertain
0.016
D
Sift4G
Benign
0.099
T
Polyphen
0.99
D
Vest4
0.23
MVP
0.91
MPC
0.63
ClinPred
0.094
T
GERP RS
4.9
Varity_R
0.22
gMVP
0.51
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56393253; hg19: chr9-101980335; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.